Amaran Biotechnology Inc. was founded in 2010, it is a contract development and manufacturing organization to provide high quality services to our clients in development, lead-in advanced technology and cGMP manufacturing of biopharmaceuticals from clinical to commercial manufacturing. Amaran’s mission is to improve the life condition of patients through manufacturing high quality and safe pharmaceuticals under international standards. The Chairman and General Manager, Dr. Tessie Che, the expert in management and operations in pharmaceutical industry. She leads the management team to build up the plant under international standards and achieves our corporate vision “Act Locally, Think Globally”.
Amaran’s facility is located in Hsinchu Biomedical Science Park, built in collaboration with international design house & professional advisory from Taiwan contractors to build up a safe and solid cGMP plant with a total floor area of 6,145 square meters.
Amaran primary focus on development and manufacturing of glycoprotein pharmaceuticals against breast cancer, supplies OBI Taiwan with OBI-821 & OBI-822 for global clinical trials and commercialization in the future. Amaran offers the advanced technology and services to become the best partner for clients from clinical to commercial manufacturing.